Medline Inc. (MDLN) News
Follow Medline Inc. (MDLN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 38 public stories across 15 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Medline shares rise after Q3 earnings beat
EQUITY | Nov 04, 2026, 07:21 PM UTC
M
Medline Shares Rise 16% After Company Raises Outlook
Medline said it now expects organic sales growth of 10% to 10.5%, up from its prior outlook, following higher third-quarter sales. Shares rose 16% to $39.67 on Wednesday and remained down 5.6% for the year.
EARNINGS | Nov 04, 2026, 07:01 PM UTC
M
Medline Reports Q3 Sales Growth and Raises 2026 Organic Sales Guidance
Medline reported third-quarter net sales of $7.856 billion, up 10.4% year over year, and net income of $318 million, down 1.2%. Adjusted diluted EPS was $0.44, exceeding analyst expectations. It raised its 2026 organic s
EARNINGS | Nov 04, 2026, 02:33 PM UTC
M
Medline Q3 Adjusted EBITDA Rises 12% to $960 Million
Medline reported Q3 2026 adjusted EBITDA of $960 million, up 12%.
EARNINGS | Nov 04, 2026, 01:06 PM UTC
M
Medline shares rise 7.1% premarket as Q3 sales rise and company announces $1 billion buyback
Medline shares rose 7.1% premarket after Q3 sales increased; the company also announced a $1 billion share repurchase program.
EQUITY | Nov 04, 2026, 12:44 PM UTC
M
Medline Reports Third-Quarter Sales of $7.86 Billion
EARNINGS | Nov 04, 2026, 12:43 PM UTC
M
Medline raises 2026 organic sales guidance to 10%-10.5%
Medline raised its 2026 organic sales guidance from 9%-10% to 10%-10.5%.
EARNINGS | Nov 04, 2026, 12:37 PM UTC
L
Medline reports Q3 EPS of $0.22
EARNINGS | Nov 04, 2026, 12:37 PM UTC
M
Medline Reports Q3 Revenue of $7.86B
Medline reported Q3 revenue of $7.86 billion, compared with a FactSet estimate of $7.72 billion.
EQUITY | Nov 04, 2026, 12:33 PM UTC
M
Medline Posts Q3 Adjusted EPS of $0.44 per Share
Medline reported Q3 adjusted EPS of $0.44 per share, versus the FactSet estimate of $0.34.
EARNINGS | Nov 04, 2026, 12:33 PM UTC
M
Medline Backs 2026 Adjusted EBITDA Guidance of $3.3B-$3.4B
EARNINGS | Nov 04, 2026, 12:32 PM UTC
M
Medline Reports Q3 Net Income of USD 318 Million
EARNINGS | Nov 04, 2026, 12:32 PM UTC
M
Medline reports Q3 revenue of USD 7,856 million
EQUITY | Nov 04, 2026, 12:32 PM UTC
M
Medline Reports Q3 Pretax Profit of $386 Million
EQUITY | Nov 04, 2026, 12:32 PM UTC
M
Medline Reports Q3 Gross Profit of USD 1,925 Million
EQUITY | Nov 04, 2026, 12:32 PM UTC
L
Medline Reports Third-Quarter EPS
EARNINGS | Nov 04, 2026, 12:30 PM UTC
M
Medline Q3'26 Earnings Preview
Medline is scheduled to report Q3'26 results on November 4 before the market opens.
EQUITY | Nov 03, 2026, 12:01 PM UTC
M
FDA Warns of Medline Bed Risks After 2 Deaths, 16 Injuries
The FDA warned of safety risks involving Medline beds and accessories after the company reported two deaths and 16 serious injuries linked to fire, entrapment and asphyxiation hazards.
REGULATION | Oct 29, 2026, 06:59 PM UTC
M
Medline to Remove or Correct Branded Beds and Accessories Over Safety Risks
The FDA says Medline is discontinuing and removing or correcting branded beds and accessories over safety risks.
REGULATION | Oct 29, 2026, 04:36 PM UTC
M
FDA Warns on Medline Beds After Two Deaths, 16 Serious Injuries
The US FDA issued a warning concerning Medline beds after two deaths and 16 serious injuries.
REGULATION | Oct 29, 2026, 04:23 PM UTC
M
FDA Says Medline Identified Potential Fire Hazard in Beds
The FDA said Medline identified a potential fire hazard in Medline-brand beds and components.
REGULATION | Oct 29, 2026, 03:52 PM UTC
M
FDA Reports Two Deaths, 16 Serious Injuries Linked to Bed Safety Issues
The FDA report counts two deaths and 16 serious injuries linked to bed safety issues as of Oct. 20, 2026.
REGULATION | Oct 29, 2026, 03:52 PM UTC
M
Medline Issues Urgent Notice for Market Exit of Beds, Accessories
Medline issued an urgent notice for the market exit of all Medline-brand beds and accessories.
EQUITY | Oct 29, 2026, 03:52 PM UTC
M
Medline Q3'26 Results Expected November 4
Medline is scheduled to report Q3'26 results before the market opens on November 4.
EQUITY | Oct 28, 2026, 11:00 AM UTC
M
Medline Starts Voluntary Removal of Medline Brand Beds, Estimates Costs Up to $220M
Medline initiated a voluntary field action to remove all Medline Brand beds and estimates related costs of up to $220 million.
EQUITY | Oct 21, 2026, 08:27 PM UTC
L
Medline to build 800,000-square-foot Michigan facility
Medline plans a new facility in Van Buren Township, Michigan, as part of a Midwestern network buildout.
EQUITY | Oct 15, 2026, 06:18 PM UTC
H
Medline Stock Plunges 13% on Product Quality Issues, Securities Fraud Probe
Medline Industries' stock experienced a significant decline of 13% following disclosures of product quality issues. A securities fraud investigation has been initiated.
EQUITY | Oct 06, 2026, 09:36 AM UTC
L
Medline Is Maintained at Buy by UBS
Ratings actions from Benzinga: GMT) Medline Price Target Cut to $43.00/Share From $45.00 by UBSRatings actions from Benzinga
NEWS | Sep 25, 2026, 04:25 PM UTC
L
MDLN: Strong growth, resilient strategy, and tech-driven efficiency underpin long-term outlook
The conference highlighted robust top-line growth, ongoing market share gains, and a disciplined approach to brand conversion and operational investments. Despite external headwinds and a reduced EBITDA outlook, long-ter
EARNINGS | Sep 15, 2026, 05:24 PM UTC
H
Shares of medical device-related companies are trading lower amid possible sympathy with Boston Scientific after that company announced it w
Shares of medical device-related companies are trading lower amid possible sympathy with Boston Scientific after that company announced it was likely to miss its FY26 and Q3 adjusted EPS and net sales growth guidance fol
EARNINGS | Sep 08, 2026, 04:05 PM UTC
L
Medline CEO and CFO scheduled to present at Morgan Stanley healthcare conference
Medline said Jim Boyle (CEO) and Mike Drazin (CFO) are scheduled to present at the Morgan Stanley 24th Annual Global Healthcare Conference in New York.
EQUITY | Sep 03, 2026, 12:37 PM UTC
L
Medline to participate in Morgan Stanley 24th Global Healthcare Conference
Medline (MDLN) announced it will participate in the Morgan Stanley 24th Annual Global Healthcare Conference.
EQUITY | Sep 03, 2026, 12:31 PM UTC
L
BTIG maintains Medline $55.00/share price target
BTIG maintained a $55.00-per-share price target for Medline.
EQUITY | Aug 27, 2026, 11:54 AM UTC
H
FDA alerts providers on Medline kits tied to BD recall
The FDA alerted healthcare providers about Medline convenience kits containing recalled Becton Dickinson antiseptic applicators, and Medline instructed customers to inspect and quarantine affected stock.
EARNINGS | Aug 13, 2026, 06:00 PM UTC
H
Gold Jumps 4%, Dow Jones Smashes Record Highs: Stock Market Today
Gold ripped 4% higher to $4,233.89 an ounce on Wednesday, its biggest one-day advance since February, as a soft private payrolls report and easing energy costs knocked down the odds of another Federal Reserve rate hike.
EARNINGS | Aug 05, 2026, 06:14 PM UTC
L
MDLN - Medline Reports Second Quarter and First Six Months 2026 Results
MDLN - Medline Reports Second Quarter and First Six Months 2026 Results
EQUITY | Aug 05, 2026, 11:30 AM UTC
H
Jim Cramer: 'Go For' AST SpaceMobile, Power Plant Maker 'Too Speculative'
On CNBC’s “ Mad Money Lightning Round,” Jim Cramer said he likes Medline Inc. (NASDAQ: MDLN ), adding that it is “probably the best IPO of the year.” Medline announced that it will report second-quarter financial results
EARNINGS | Jul 02, 2026, 11:39 AM UTC
H
Thursday Morning Online Reading Summary
PROJECT SYNDICATE -Shashi Tharoor, a former UN under-secretary-general and former Indian Minister of State for External Affairs and Minister of State for Human Resource Development, and a current MP for the Indian Nation
RATES | Jul 02, 2026, 11:00 AM UTC